Global Influenza Vaccine Market Research Report 2023

Global Influenza Vaccine Market Research Report 2023

Table of Contents
1 Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Influenza Vaccine
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Influenza Vaccine Segment by Application
1.3.1 Global Influenza Vaccine Market Value by Application: (2023-2029)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza Vaccine Revenue 2018-2029
1.4.2 Global Influenza Vaccine Sales 2018-2029
1.4.3 Global Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Influenza Vaccine Market Competition by Manufacturers
2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Influenza Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Vaccine, Product Type & Application
2.7 Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Influenza Vaccine Global Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Influenza Vaccine Sales by Region: 2018-2023
3.2.2 Global Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Influenza Vaccine Global Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Influenza Vaccine Revenue by Region: 2018-2023
3.3.2 Global Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Influenza Vaccine Sales by Type (2018-2023)
4.1.2 Global Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Influenza Vaccine Revenue by Type (2018-2023)
4.2.2 Global Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Influenza Vaccine Sales by Application (2018-2023)
5.1.2 Global Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Influenza Vaccine Revenue by Application (2018-2023)
5.2.2 Global Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GSK Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Viatris Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hualan Bio Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Changchun Institute of Biological Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sinovac Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BCHT Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jiangsu GDK Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Influenza Vaccine Description and Business Overview
6.11.3 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 KM Biologics Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Vaccine Industry Chain Analysis
7.2 Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Vaccine Production Mode & Process
7.4 Influenza Vaccine Sales and Marketing
7.4.1 Influenza Vaccine Sales Channels
7.4.2 Influenza Vaccine Distributors
7.5 Influenza Vaccine Customers
8 Influenza Vaccine Market Dynamics
8.1 Influenza Vaccine Industry Trends
8.2 Influenza Vaccine Market Drivers
8.3 Influenza Vaccine Market Challenges
8.4 Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Influenza Vaccine Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Influenza Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Influenza Vaccine Sales by Region (2018-2023) & (M Units)
Table 18. Global Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Influenza Vaccine Sales by Region (2024-2029) & (M Units)
Table 20. Global Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 27. North America Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 28. North America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 32. Europe Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 33. Europe Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Influenza Vaccine Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Influenza Vaccine Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Influenza Vaccine Sales (M Units) by Type (2018-2023)
Table 51. Global Influenza Vaccine Sales (M Units) by Type (2024-2029)
Table 52. Global Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Influenza Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Influenza Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Influenza Vaccine Sales (M Units) by Application (2018-2023)
Table 61. Global Influenza Vaccine Sales (M Units) by Application (2024-2029)
Table 62. Global Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Influenza Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Influenza Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi Influenza Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CSL Influenza Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GSK Influenza Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Viatris Influenza Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. AstraZeneca Influenza Vaccine Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hualan Bio Influenza Vaccine Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Corporation Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Changchun Institute of Biological Influenza Vaccine Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sinovac Influenza Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. BCHT Corporation Information
Table 111. BCHT Description and Business Overview
Table 112. BCHT Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. BCHT Influenza Vaccine Product
Table 114. BCHT Recent Developments/Updates
Table 115. Jiangsu GDK Corporation Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Jiangsu GDK Influenza Vaccine Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Corporation Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. KM Biologics Influenza Vaccine Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Influenza Vaccine Distributors List
Table 128. Influenza Vaccine Customers List
Table 129. Influenza Vaccine Market Trends
Table 130. Influenza Vaccine Market Drivers
Table 131. Influenza Vaccine Market Challenges
Table 132. Influenza Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Global Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Influenza Vaccine Sales (2018-2029) & (M Units)
Figure 13. Global Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Influenza Vaccine Report Years Considered
Figure 15. Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Latin America Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 41. Latin America Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 42. Mexico Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Brazil Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Argentina Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 46. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 47. Turkey Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. UAE Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Global Sales Market Share of Influenza Vaccine by Type (2018-2029)
Figure 51. Global Revenue Market Share of Influenza Vaccine by Type (2018-2029)
Figure 52. Global Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 53. Global Sales Market Share of Influenza Vaccine by Application (2018-2029)
Figure 54. Global Revenue Market Share of Influenza Vaccine by Application (2018-2029)
Figure 55. Global Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 56. Influenza Vaccine Value Chain
Figure 57. Influenza Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs